Nektaria Simiantonaki
- Oncology top 5%
- Immunology top 10%
- Molecular Biology
- Cancer Research top 10%
- Genetics
- Co-authors
- Caren JayasingheC. James KirkpatrickT JungingerPeter R. GalleMarkus MoehlerCarl C. SchimanskiUrsula Kurzik‐DumkeU. Gönner
- Topics
- Angiogenesis and VEGF in Cancer (7 papers)Cancer Cells and Metastasis (5 papers)Cancer Research and Treatments (4 papers)
- Cited by
- OncologyImmunologyCancer Research
In The Last Decade
Nektaria Simiantonaki
23 papers receiving 815 citations
Peers
Comparison fields: 5 of 86
- Oncology 476
- Immunology 339
- Molecular Biology 296
- Cancer Research 169
- Genetics 63
Countries citing papers authored by Nektaria Simiantonaki
This map shows the geographic impact of Nektaria Simiantonaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nektaria Simiantonaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nektaria Simiantonaki more than expected).
Fields of papers citing papers by Nektaria Simiantonaki
This network shows the impact of papers produced by Nektaria Simiantonaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nektaria Simiantonaki. The network helps show where Nektaria Simiantonaki may publish in the future.
Co-authorship network of co-authors of Nektaria Simiantonaki
This figure shows the co-authorship network connecting the top 25 collaborators of Nektaria Simiantonaki. A scholar is included among the top collaborators of Nektaria Simiantonaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nektaria Simiantonaki. Nektaria Simiantonaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 10 | |
| 3 | 13 | |
| 4 | 13 | |
| 5 | 9 | |
| 6 | 9 | |
| 7 | 8 | |
| 8 | 62 | |
| 9 | 25 | |
| 10 | Epithelial expression of VEGF receptors in colorectal carcinomas and their relationship to metastatic status. | 18 |
| 11 | 51 | |
| 12 | 141 | |
| 13 | 33 | |
| 14 | 11 | |
| 15 | 4 | |
| 16 | 5 | |
| 17 | 218 | |
| 18 | 31 | |
| 19 | [Histopathologic examination of rectal carcinoma]. | 1 |
| 20 | 93 |
About Nektaria Simiantonaki
Nektaria Simiantonaki is a scholar working on Oncology, Biotechnology and Cancer Research, having authored 24 papers that have together received 836 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (7 papers), Cancer Cells and Metastasis (5 papers) and Cancer Research and Treatments (4 papers). The work is most often cited by research in Oncology (476 citations), Immunology (339 citations) and Cancer Research (169 citations). Nektaria Simiantonaki has collaborated with scholars based in Germany, Austria and Italy. Frequent co-authors include Caren Jayasinghe, C. James Kirkpatrick, T Junginger, Peter R. Galle, Markus Moehler, Carl C. Schimanski, Ursula Kurzik‐Dumke, U. Gönner, Martin R. Berger and Ines Gockel. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.